Ozempic and other weight loss drugs may be linked to conditions that could lead to blindness, study says

Popular diabetes and weight-loss drugs, including Ozempic (NVO) and Zepbound (LLY), may have a potential link with several eye conditions that can cause vision loss, according to a new investigatory review published recently in the scientific journal JAMA Ophthalmology.

Read more…

​Popular diabetes and weight-loss drugs, including Ozempic (NVO) and Zepbound (LLY), may have a potential link with several eye conditions that can cause vision loss, according to a new investigatory review published recently in the scientific journal JAMA Ophthalmology.Read more…